Could immunotherapy treat urothelial carcinoma in a woman?

Question

Hi doctor,

I am a 57-year-old woman diagnosed with metastatic urothelial carcinoma eight months ago. The urothelial cancer started in my ureter and has spread to my lungs and bones.

I have been on first-line platinum-based chemotherapy (Gemcitabine and Cisplatin) for six months. While there was an initial tumor response, my latest CT shows new liver metastases, indicating disease progression.

My oncologist mentioned the need for second-line treatment. So kindly provide your insight on the following -

Could you outline current options for advanced urothelial cancer when chemotherapy stops working? I am particularly interested in immunotherapy, targeted therapies, antibody-drug conjugates, and promising clinical trials.
Also, how can I weigh the benefits of continued treatment against maintaining my quality of life at this stage?

Thank you.

Answer 1

Hello,

Welcome to icliniq.com.

I understand your concern.

Here are some advanced treatment options for metastatic urothelial carcinoma (a type of cancer that starts in the lining of the urinary tract, which includes the bladder, ureters, and renal pelvis) after chemotherapy:

Immunotherapy is a key second-line option. These drugs help your immune system recognize and attack urothelial cancer cells. Common agents include immune checkpoint inhibitors. Side effects may include fatigue, skin rash, or autoimmune reactions. Discuss eligibility with your oncologist.
If your tumor has specific genetic mutations, like FGFR (fibroblast growth factor receptor) mutations or fusions, you may qualify for targeted drugs. These therapies block specific pathways that allow cancer cells to grow and spread. If not already done, your doctor may suggest genetic testing of the tumor.
Consider enrolling in a clinical trial to access promising experimental therapies, such as:
- Antibody-drug conjugates (ADCs) – Deliver chemo directly to tumor cells while sparing healthy tissue.
- CAR-T cell therapy or personalized cancer vaccines – Boost immune targeting of cancer.

These emerging treatments offer hope when standard chemotherapy stops working. However, each comes with potential risks and benefits. It’s essential to talk to your oncologist to decide what aligns best with your health goals and quality of life.

I suggest you consult an oncologist, talk to them, and take medications with their consent.

I hope this has helped you.

Kindly follow up if you have more doubts.

Thank you.